Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs

CMAJ. Canadian Medical Association Journal

Volumn 155, Issue 4, 1996, Pages 377-383

  Marshall, Kenneth G ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL ETHICS; MORBIDITY; MORTALITY; PATIENT INFORMATION; PERIODIC MEDICAL EXAMINATION; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; REVIEW; RISK BENEFIT ANALYSIS; SCREENING;

EID: 0029811970     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Vevaina JR, Nora LM, Bone RC. Issues in biomedical ethics. Dis Mon 1993;39:869-928.
2. Lee JM. Screening and informed consent. N Engl J Med 1993;328:438-40.
3. Marshall KG. Screening for prostate cancer. How can patients give informed consent? Can Fam Physician 1993;39: 2385-90.
4. Skrabanek P. The physician's responsibility to the patient. Lancet 1988;1:1155-7.
5. Skrabanek P. The Death of Humane Medicine. Bury Saint Ednumds, England: Saint Edmundsbury Press, 1994:31-7.
6. Skrabanek P. Why is preventive medicine exempted from ethical constraints? J Med Ethics 1990;16:187-90.
7. Hahn DL, Roberts RG. PSA screening for asymptomatic prostate cancer: truth in advertising [editorial]. J Fam Pract 1993;37:432-4.
8. Glode LM. Prostate cancer screening: a place for informed consent? [editorial]. Hosp Pract 1994;29:10-2.
9. Cassel CK. Breast cancer screening in older women: ethical issues. J Gerontol 1992;47(spec iss): 126-30.
10. Edwards PJ, Hall DM. Screening, ethics, and the law. BMJ 1992;305:267-8.
11. Waldron G. Serum screening for Down syndrome. Informed consent is vital [letter]. BMJ 1993;307:500-1.
12. Beauchamp TL. Informed consent. In: Veatch RM, editor. Medical ethics. Boston: Jones and Bartlett Publishers, 1989:173-200.
13. Deber RB. Physicians in health care management: 7. The patient-physician partnership: changing roles and the desire for information. Can Med Assoc J 1994;151:171-6.
14. Deber RB. Physicians in health care management: 8. The patient-physician partnership: decision making, problem solving and the desire to participate. Clin Med Assoc J 1994;151: 423-7.
15. Black WC, Nease RF, Tosteson A. Perceptions of breast cancer risk and screening effectiveness in women under 50. J Natl Cancer Inst 1995;87:720-31.
16. French K, Porter AMD, Robinson SE, McCallum FM, Howie JGR, Roberts MM. Attendance at a breast screening clinic: a problem of administration or attitudes. BMJ 1982;285:617-20.
17. Roberts M. Breast screening: Time for a rethink? BMJ 1989;299:1153-5.
18. Schapira DV, Pamies RJ, Kumar NB, Herold AH, Van Durme DJ, Woodward LJ, et al. Cancer screening. Knowledge, recommendations, and practices of physicians. Cancer 1993;71:839-43.
19. Baines CJ. Women and breast cancer: Is it really possible for the public to be well informed? [editorial]. Can Med Assoc J 1992;146:2147-8.
20. Cochrane AL, Holland WW. Validation of screening procedures. Br Med Bull 1971;27:3-8.
21. Holland WW. Screening: reasons to be cautious. Stringent criteria must be met before implementation. BMJ 1993;306: 1222-3.
22. McCormick J. Health promotion: the ethical dimension. Lancet 1994;344:390-1.
23. O'Hagan J. The ethics of informed consent in relation to prevention screening programmes. N Z Med J 1991;104:122-5.
24. Butler JA. Prevention may be more expensive than cure. J R Soc Med 1993;86:341-4.
25. McCormick J, Skrabanek P. Coronary heart disease is not preventable by population interventions. Lancet 1988;2:839-41.
26. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ 1994;308:313-20.
27. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ 1994;308:308-12.
28. Strandberg TE, Salomaa VV, Naukkarinen VA, Vanhanen HT, Sarna SJ, Miettinen TA. Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA 1991;266:1225-9.
29. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985;14:32-8.
30. Veatch RM, editor. Medical Ethics. Boston: Jones and Bartlett Publishers, 1989.
31. Mappes TA, Zembaty JS. Biomedical Ethics. 3rd ed. New York: McGraw-Hill, 1991.
32. Woolf SH. Practice guidelines: a new reality in medicine: III. Impact on patient care. Arch Intern Med 1993;153:2646-55.
33. Conroy M, Shannon W. Clinical guidelines: their implementation in general practice. Br J Gen Pract 1995;45:371-5.
34. Oxman AD, Thomson MA, Davis DA, Haynes B. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995;153: 1423-31.
35. Haynes RB. Some problems in applying evidence in clinical practice. Ann N Y Acad Sci 1993;703:210-24. (discussion 224-5).
36. Baum M. Informed consent may increase non-attendance rate [letter]. BMJ 1995;310:1003.
37. Annas GJ. Breast cancer screening in older women: law and patient rights. J Gerontol 1992;47(spec iss):121-5.
38. Walsworth-Bell JP. Doctors should admit uncertainty [letter]. BMJ 1993;307:1495.
39. Hux JE, Naylor CD. Communicating the benefits of chronic preventive therapy: Does the format of efficacy data determine patients' acceptance of treatment? Med Decis Making 1995;15:152-7.
40. Woolf SH. Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. N Engl J Med 1995;333:1401-5.
41. Carrese JA, Rhodes LA. Western bioethics on the Navajo Reservation. JAMA 1995;274:826-9.
42. Blackhall LJ, Murphy ST, Frank G, Michel V, Azen S. Ethnicity and attitudes toward patient autonomy. JAMA 1995;274:820-5.
43. Gostin LO. Informed consent, cultural sensitivity, and respect for persons [editorial]. JAMA 1995;274:844-5.
44. Collins JA. Hormone replacement therapy and breast cancer: What is happening? J Soc Obstet Gynaecol Can 1995;17:1-10.
45. Angell M, Kassirer JP. Clinical research - What should the public believe? [editorial]. N Engl J Med 1994;331:189-90.
46. Krahn M, Naylor CD, Basinski AS, Detsky AS. Comparison of an aggressive (US) and a less aggressive (Canadian) policy for cholesterol screening and treatment. Ann Intern Med 1991;115:248-55.
47. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada, 1994:791.
48. US Preventive Services Task Force. An Assessment of the Effectiveness of 169 Interventions. Baltimore: Williams and Wilkins, 1989.
49. Csaja R, McFall SL, Warnecke RB, Ford L, Kaluzny AD. Preferences of community physicians for cancer screening guidelines. Ann Intern Med 1994;120:602-8.
50. Battista RN, Hodge MJ, Vineis P. Medicine, practice and guidelines: the uneasy juncture of science and art. J Clin Epidemiol 1995;48:875-80.
51. Sox HC. Preventive health services in adults. N Engl J Med 1994;330:1589-95.
52. Stephenson MJ. Gestational diabetes mellitus [editorial]. Can Fam Physician 1993;39:745-8.
53. Jeyapragasan M, Morris B. Are you a maximalist, a minimalist, or a ritualist? [letter]. Can Fam Physician 1993;39: 1878,1881.
54. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada, 1994.
55. Beisecker AE, Beisecker TD. Patient information-seeking behaviors when communicating with doctors. Med Care 1990;28:19-28.
56. Foundation for Informed Medical Decision Making. The PSA Decision: What You Need to Know [videotape]. Hanover, NH: The Foundation, 1994.
57. Lyon HC, Henderson JV, Beck JR, Mulley AG, Barry MJ, Fowler FJ J, et al. A multipurpose interactive videodisc with ethical, legal, medical, educational and research implications: the informed patient decision-making procedure. In: Kingsland LC, editor. Proceedings. The 13th Annual Symposium on Computer Applications in Medical Care; 1989 Nov 5-8, Washington. New York: Institute of Electrical and Electronics Engineers, 1989:1043-5.